Clinical Study
Acute Hyperglycemia Does Not Impair Microvascular Reactivity and Endothelial Function during Hyperinsulinemic Isoglycemic and Hyperglycemic Clamp in Type 1 Diabetic Patients
Table 1
Biochemical parameters, parameters of insulin sensitivity and microvascular reactivity during isoglycemic (ISO) and hyperglycemic (HYPER) hyperinsulinemic clamp and during the control test in Type 1 diabetic patients.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statistical significance of differences as compared to clamp and control test baseline values: a, b, cand x when comparing isoglycemic and hyperglycemic phase. M: glucose disposal rate, MCRG: metabolic clearance of glucose, MCRG/I: insulin sensitivity index, TC: total cholesterol, HDL-C: HDL-cholesterol, LDL-C: LDL-cholesterol, TG: triglycerides, MDA: malonyl dialdehyde, ICAM-1: intercellular cell adhesion molecule 1, VCAM: vascular cell adhesion molecule, PORHmax-fi: maximal perfusion during postocclusive reactive hyperemia at fingertip, PORHtmax-fi: time to maximal perfusion during postocclusive reactive hyperemia at fingertip, PORHmax/t-fi: velocity of perfusion increase during post-occlusive reactive hyperemia at fingertip, PORHmax-fo: maximal perfusion during post-occlusive reactive hyperemia in forearm, PORHtmax-fo: time maximal perfusion during post-occlusive reactive hyperemia in forearm, PORHmax/t-fo: velocity of perfusion increase during post-occlusive reactive hyperemia in forearm, THmax-fo: maximal perfusion during thermal hyperemia, THtmax-fo: time to maximal perfusion during thermal hyperemia, and THmax/t-fo: velocity of perfusion increase during thermal hyperemia. |